CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $151,424,000 | -2.2% | 4,480 | -32.3% | 0.00% | – |
| Q1 2021 | $154,795,000 | +60.9% | 6,618 | +98.1% | 0.00% | – |
| Q4 2020 | $96,192,000 | -40.1% | 3,340 | -57.8% | 0.00% | – |
| Q3 2020 | $160,540,000 | +70.2% | 7,924 | +152.4% | 0.00% | – |
| Q2 2020 | $94,327,000 | -47.7% | 3,139 | -45.3% | 0.00% | – |
| Q1 2020 | $180,440,000 | +57.8% | 5,741 | +136.4% | 0.00% | – |
| Q4 2019 | $114,383,000 | +595.2% | 2,428 | -4.7% | 0.00% | – |
| Q3 2019 | $16,454,000 | -31.2% | 2,547 | +30.7% | 0.00% | – |
| Q2 2019 | $23,921,000 | -46.7% | 1,948 | -41.2% | 0.00% | – |
| Q1 2019 | $44,878,000 | +14057.1% | 3,312 | +4092.4% | 0.00% | – |
| Q4 2018 | $317,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |